<html>
<head>PUBMED IDs for FUSSEL18</head>
<body bgcolor='#C5F0F2'><h1>FUSSEL18</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17334996/'>High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.</a> March 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18559491/'>Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.</a> June 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19934318/'>Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.</a> January 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20029986/'>HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas.</a> May 21  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20029985/'>Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer.</a> December 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20029976/'>Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.</a> March 10  2009<br></body></html>
